Diamedica Therapeutics share price logo

Diamedica Therapeutics

NASDAQ: DMAC

Small Cap

$6.34

-0.05

(-0.78%)

as on

Diamedica Therapeutics Stock Performance

as on September 1, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $6.22
    $6.59
    downward going graph

    1.89%

    Downside

    3.94%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.14
    $10.42
    downward going graph

    18.93%

    Downside

    64.35%

    Upside

    downward going graph

Diamedica Therapeutics share price movements today

Previous Close
$6.39
Open
$6.44
Volume
319.9K
Market Cap
$344.6M
Day's Low - High
$6.22 - $6.59
52 Week Low - High
$5.14 - $10.42

Diamedica Therapeutics Historical Returns

1 Month Return
+ 0.79 %
3 Month Return
+ 6.68 %
1 Year Return
+ 11.91 %
3 Year Return
+ 116.61 %
5 Year Return
+ 48.6 %

Diamedica Therapeutics Stock Fundamentals & Key Indicators

Check Diamedica Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$344.6M

EPS (TTM)

-0.8125

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-39.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-114.62%

Diamedica Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Diamedica Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$344.6M48.6%NA0.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$137.2B170.45%31.9286.04%NA
BUY$55.1B-63.37%-7.98-12.57%NA
BUY$85.8B17.94%19.984.86%0.44%

Stock Returns calculator for Diamedica Therapeutics Stock including INR - Dollar returns

The Diamedica Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Diamedica Therapeutics investment value today

Current value as on today

₹1,20,056

Returns

₹20,056

(+20.06%)

Returns from Diamedica Therapeutics Stock

₹11,033 (+11.03%)

Dollar Impact

₹9,023 (+9.02%)

Analyst Recommendation on Diamedica Therapeutics Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Diamedica Therapeutics. Average target price of $15.5

Diamedica Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Diamedica Therapeutics.

What analysts predicted

59.1%UPSIDE

Target Price

$15.5

Current Price

$6.34

Analyzed by

3 Analysts

Target

$15.50

Diamedica Therapeutics target price $15.5, a slight upside of 59.1% compared to current price of $6.34. According to 3 analysts rating.

Indian Investors' Interest in Diamedica Therapeutics Stock

Search interest for Diamedica Therapeutics Stock has decreased by -87% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-87% versus previous 30 day period

Diamedica Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
13
-
-
-
0
-
Gross Profit
0
0
-6
0
0
0
0
0
0
Operating Income
-5
-5
-6
-8
-8
-8
-9
-9
-10
EBITDA
-5
-5
-6
-7
-7
-7
-8
-8
-10
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-5
-6
-7
-7
-7
-8
-8
-10
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
-5
-5
-6
-7
-7
-7
-8
-8
-10
Net Profit Margin
0.00%
0.00%
0.00%
-57.24%
0.00%
0.00%
0.00%
31215.40%
0.00%

Diamedica Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
0
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
-
Operating Income
-2
-4
-6
-11
-12
-13
-14
-21
-26
-34
EBITDA
-2
-4
-5
-11
-12
-13
-13
-19
-24
-32
Interest Expense
0
-
-
0
0
0
0
-
-
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-4
-5
-10
-12
-13
-13
-19
-24
-32
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-2
-4
-5
-10
-12
-13
-13
-19
-24
-32
Net Profit Margin
0.00%
0.00%
-1146.80%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Diamedica Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-5
-6
-7
-7
-7
-8
-8
-10
-10
Operating Cash Flow
-4
-4
-6
-7
-7
-6
-7
-9
-8
Investing Cash Flow
4
-5
5
6
8
-26
7
-2
8
Financing Cash Flow
11
0
0
0
0
32
12
0
0
Change in Cash
11
-9
-1
0
1
0
12
-10
0

Diamedica Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-5
-10
-12
-13
-13
-19
-24
-32
Operating Cash Flow
-3
-5
-9
-9
-12
-11
-18
-22
-29
Investing Cash Flow
0
0
-3
-16
-20
11
-18
8
-2
Financing Cash Flow
3
21
0
28
30
0
36
11
43
Change in Cash
0
15
-12
3
-2
0
0
-1
12

Mutual Funds that own Diamedica Therapeutics Stock

Check out the Mutual Funds with significant holdings in Diamedica Therapeutics.

Funds
Holdings
Shares Held
Fidelity Salem Street Trust
0.687177%
370565
VANGUARD INDEX FUNDS
0.618361%
333456
Fidelity Concord Street Trust
0.612885%
330503
VANGUARD SCOTTSDALE FUNDS
0.373742%
201543
Jacob Funds Inc.
0.171958%
92730

Global Institutional Holdings in Diamedica Therapeutics

Funds
Holdings
iShares
2.57%
Vanguard
1.13%
SPDR
0.17%
Xtrackers
0.06%
Global X
0.03%

Insights on Diamedica Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, DMAC has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 472.8% return, outperforming this stock by 460.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 30.83M → -27.99K (in $), with an average decrease of 77.7% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, DMAC stock has moved down by -5.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 5 quarters, -7.69M → -10.13M (in $), with an average decrease of 7.3% per quarter

About Diamedica Therapeutics

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal growth restriction. The company develops DM300, which is a recombinant human ulinastatin in the preclinical stage for the treatment of inflammatory diseases, such as acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
OrganisationDiamedica Therapeutics
Headquarters301 Carlson Parkway, Minneapolis, MN, United States, 55305
IndustryBiotechnology
CEOMr. Dietrich John Pauls MBA
E-voting on sharesClick here to vote

Key Management of Diamedica Therapeutics

Name

Title

Mr. Dietrich John Pauls MBA

President, CEO & Director

Mr. Scott Kellen CPA

CFO & Corporate Secretary

Dr. Julie Krop M.D.

Chief Medical Officer

Dr. Ambarish Shah Ph.D.

Chief Technology Officer

Mr. Dominic R. Cundari

Chief Commercial Officer

FAQs

What is Diamedica Therapeutics share price today?

Diamedica Therapeutics share price today is $6.34 as on at the close of the market. Diamedica Therapeutics share today touched a day high of $6.59 and a low of $6.22.

What is the 52 week high and 52 week low for Diamedica Therapeutics share?

Diamedica Therapeutics share touched a 52 week high of $10.42 on and a 52 week low of $5.14 on . Diamedica Therapeutics stock price today i.e. is closed at $6.34,which is 39.15% down from its 52 week high and 23.35% up from its 52 week low.

What is Diamedica Therapeutics's market capitalisation today?

Diamedica Therapeutics market capitalisation is $0.00T as on .

How to invest in Diamedica Therapeutics Stock (DMAC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Diamedica Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Diamedica Therapeutics Shares that will get you 0.2366 shares as per Diamedica Therapeutics share price of $6.34 per share as on September 1, 2026 at 1:29 am IST.

What is the minimum amount required to buy Diamedica Therapeutics Stock (DMAC) from India?

Indian investors can start investing in Diamedica Therapeutics (DMAC) shares with as little as ₹95.152 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹951.52 in Diamedica Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Diamedica Therapeutics share’s latest price of $6.34 as on September 1, 2026 at 1:29 am IST, you will get 1.5773 shares of Diamedica Therapeutics. Learn more about fractional shares .

What are the returns that Diamedica Therapeutics has given to Indian investors in the last 5 years?

Diamedica Therapeutics stock has given 48.6% share price returns and 30.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?